The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab von Panovská, Anna, Smolej, Lukáš, Lysák, Daniel, Brychtová, Yvona, Šimkovič, Martin, Motyčková, Monika, Vodárek, Pavel, Lindtnerová, Michaela, Trbušek, Martin, Malčíková, Jitka, Pospíšilová, Šárka, Mayer, Jiří, Doubek, Michael

Volltext

The Fate of Chronic Lymphocytic Leukemia Patients After Failure of Fludarabine, Cyclophosphamide, and Rituximab Regimen von Panovska, Anna, Lysák, Daniel, Smolej, Lukas, Brychtova, Yvona, Simkovic, Martin, Motyckova, Monika, Lindtnerova, Michaela, Trbusek, Martin, Malcikova, Jitka, Pospisilova, Sarka, Mayer, Jiri, Doubek, Michael

Volltext

Ofatumumab Added To Dexamethasone In Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia. Results From a Phase II Study Of The Czech Leukemia Study Group For Life von Doubek, Michael, Brychtova, Yvona, Panovska, Anna, Trizuljak, Jakub, Sebejova, Ludmila, Stehlikova, Olga, Chovancova, Jana, Malcikova, Jitka, Smardova, Jana, Plevova, Karla, Volfova, Pavlina, Trbusek, Martin, Mraz, Marek, Majercakova, Denisa, Obrtlikova, Petra, Karban, Josef, Smolej, Lukas, Lindtnerova, Michaela, Oltova, Alexandra, Jelinkova, Eva, Pospisilova, Sarka, Mayer, Jiri

Volltext